Literature DB >> 2298974

Follow-up MR studies in Hallervorden-Spatz disease.

M Gallucci1, F Cardona, M Arachi, A Splendiani, A Bozzao, R Passariello.   

Abstract

Follow-up magnetic resonance (MR) studies of a child affected by Hallervorden-Spatz disease were performed over a period of 3 years. The hyperintense pallidi shown in the first examination changed to a mixed intensity target-like appearance. All the patterns observed in our patient have been described in the literature but in different subjects. Our data show these findings to be different manifestations of the same disease during its evolution.

Entities:  

Mesh:

Year:  1990        PMID: 2298974     DOI: 10.1097/00004728-199001000-00022

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  6 in total

1.  Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life.

Authors:  L Angelini; N Nardocci; V Rumi; C Zorzi; L Strada; M Savoiardo
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

2.  Clinicopathological study of familial late infantile Hallervorden-Spatz disease: a particular form of neuroacanthocytosis.

Authors:  A Malandrini; G M Fabrizi; P Bartalucci; C Salvadori; G Berti; C Sabò; G C Guazzi
Journal:  Childs Nerv Syst       Date:  1996-03       Impact factor: 1.475

Review 3.  Neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

4.  MRI in a case of rigid Huntington's disease.

Authors:  S Spieker; D Petersen; M Poremba
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

5.  Early clinical and imaging (high-field MRI) diagnosis of Hallervorden-Spatz disease.

Authors:  M Feliciani; P Curatolo
Journal:  Neuroradiology       Date:  1994-04       Impact factor: 2.804

Review 6.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.